Granules India informs about company updates

06 Aug 2019 Evaluate

Granules India has informed that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the company for Amphetamine Sulfate Tablets USP 5 mg and 10 mg. It is bioequivalent to the reference listed drug product (RLD), Evekeo Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC. Amphetamine Sulfate tablets is a central nervous system stimulant used to treat sleep disorder, increase attention, decrease impulsiveness and hyperactivity in patients with Attention Deficit Hyperactivity Disorder (ADHD). 

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

579.90 14.95 (2.65%)
27-Jan-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.60
Dr. Reddys Lab 1240.50
Cipla 1303.75
Zydus Lifesciences 890.00
Lupin 2139.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×